4//SEC Filing
SHERWIN STEPHEN A 4
Accession 0000914475-24-000160
CIK 0000914475other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:38 PM ET
Size
14.2 KB
Accession
0000914475-24-000160
Insider Transaction Report
Form 4
SHERWIN STEPHEN A
Director
Transactions
- Exercise/Conversion
Common Stock
2024-05-29$42.76/sh+25,000$1,069,000→ 51,504 total - Exercise/Conversion
Common Stock
2024-05-29$47.89/sh+15,000$718,350→ 41,504 total - Sale
Common Stock
2024-05-29$133.47/sh−15,000$2,002,010→ 26,504 total - Sale
Common Stock
2024-05-29$133.46/sh−25,000$3,336,555→ 26,504 total - Exercise/Conversion
Non-Qualified Stock Option
2024-05-29−25,000→ 0 totalExercise: $42.76Exp: 2025-05-28→ Common Stock (25,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option
2024-05-29−15,000→ 0 totalExercise: $47.89Exp: 2026-05-20→ Common Stock (15,000 underlying)
Footnotes (5)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2024.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.22 to $136.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.00 to $136.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025.
- [F5]The option was granted May 20, 2016 and vested in 12 equal monthly installments beginning June 20, 2016. These options will expire ten years from the date of grant on May 20, 2026.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001079462
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 4:38 PM ET
- Size
- 14.2 KB